A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

Clinical trial NCT05462873 · TERMINATED

Trial details

NCT number: NCT05462873
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Carcinoma, Renal Cell Esophageal Squamous Cell Carcinoma Squamous Cell Carcinoma of Head and Neck

Start date: 2023-04-04
Primary completion: 2026-01-26
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.